Natural Capsules Ltd

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.148 today, marking a significant decline in its stock price amid ongoing financial difficulties and persistent negative results.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 02 March 2026, providing investors with the latest insights into its performance and prospects.

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.151.2 today, marking a significant decline amid ongoing financial pressures and market headwinds.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis below is based on the company’s current fundamentals, returns, and financial metrics as of 19 February 2026, providing investors with an up-to-date perspective on the stock’s position.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 08 February 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Natural Capsules Ltd has touched a new 52-week low of Rs.152 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial performance and market positioning within the Pharmaceuticals & Biotechnology sector.

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.152 today, marking a significant decline in its stock price amid ongoing challenges and sector dynamics.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Natural Capsules Ltd has touched a new 52-week low of Rs.155.65 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial performance and market positioning.

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.155.65 today, marking a significant decline amid ongoing downward momentum. The stock’s performance continues to trail its sector and benchmark indices, reflecting persistent pressures on its valuation and financial metrics.

Natural Capsules Ltd touched a new 52-week low of Rs.160.45 today, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning. The stock’s fall comes despite an initial gap-up opening and intraday volatility, reflecting persistent pressures within the Pharmaceuticals & Biotechnology sector.

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, has declined to a fresh 52-week low of Rs.163, marking a significant downturn in its stock performance amid persistent financial headwinds and sector underperformance.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Natural Capsules Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge on 2 Jan 2026, hitting its upper circuit limit with a maximum daily gain of 9.99%. This sharp rally was driven by strong buying interest, elevated investor participation, and a significant unfilled demand, signalling renewed optimism despite the company’s recent downgrade to a Strong Sell rating by MarketsMOJO.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 December 2025, providing investors with the latest comprehensive view of the company’s position.

Natural Capsules, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price action over the longer term.